Answers are grounded in this paper and cite their sources.
Autophagy-based protein degradation is emerging as a promising technology for anti-diseases and innovative drug discovery. Here, we demonstrate a novel type of autophagy-targeting chimera (AUTAC) to degrade protein by targeting autophagy key protein LC3. The best compound 10f powerfully degraded BRD4 protein through the autophagy pathway and exhibited good anti-proliferative activity in multiple tumor cells, providing a powerful toolbox for medicinal chemists to study disease-related targets with autophagy-based degradation.
No takes yet. Share an insight, caveat, or question.
Pei et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: